Rituximab for remission induction in elderly patients with ANCA-associated vasculitis

Seminars in Arthritis and Rheumatism

Volumn 45, Issue 1, 2015, Pages 67-69

  Timlin, H ^a   Lee, S M ^a   Manno, R L ^a   Seo, P ^a   Geetha, Duvura ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

AAV (ANCA associated vasculitis); CYC (cyclophosphamide); Elderly; Eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome); Granulomatosis with polyangiitis (Wegener's); MAb (monoclonal antibody); Microscopic polyangiitis (MPA); Renal limited vasculitis; RTX (rituximab)

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; MYCOPHENOLATE MOFETIL; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RITUXIMAB; IMMUNOLOGIC FACTOR;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; BACTERIAL PNEUMONIA; BIRMINGHAM VASCULITIS ACTIVITY SCORE WEGENER GRANULOMATOSIS; CLINICAL ARTICLE; DERMATITIS HERPETIFORMIS; DISEASE ACTIVITY SCORE; DRUG EFFICACY; DRUG WITHDRAWAL; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; INFUSION RELATED REACTION; LEUKOPENIA; LUNG HEMORRHAGE; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PULMONARY CANDIDIASIS; RELAPSE; REMISSION; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RITUXIMAB; TREATMENT OUTCOME;

EID: 84937724154     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2015.02.005     Document Type: Article

References (15)

1. Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 2001, 13:48-55.
2. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
3. Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, et al. Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis, 69:1036-1043.
4. Flossmann O., Berden A., de Groot K., Hagen C., Harper L., Heijl C., et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011, 70:488-494.
5. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med, 363:221-232.
6. Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med, 363:211-220.
7. Jayne D. Current attitudes to the therapy of vasculitis. Kidney Blood Press Res 2003, 26:231-239.
8. Bomback A.S., Appel G.B., Radhakrishnan J., Shirazian S., Herlitz L.C., Stokes B., et al. ANCA-associated glomerulonephritis in the very elderly. Kidney Int 2011, 79:757-764.
9. Franssen C.F., Stegeman C.A., Kallenberg C.G., Gans R.O., De Jong P.E., Hoorntje S.J., et al. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 2000, 57:2195-2206.
10. Haris A., Polner K., Aranyi J., Braunitzer H., Kaszas I., Mucsi I. Clinical outcomes of ANCA-associated vasculitis in elderly patients. Int Urol Nephrol 2014, 46:1595-1600.
11. Harper L., Savage C.O. ANCA-associated renal vasculitis at the end of the twentieth century-a disease of older patients. Rheumatology (Oxford) 2005, 44:495-501.
12. Ntatsaki E., Watts R.A., Scott D.G. Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am 2010, 36:447-461.
13. Hoganson D.D., From A.M., Michet C.J. ANCA vasculitis in the elderly. J Clin Rheumatol 2008, 14:78-81.
14. CDC: The state of aging and health in America; 2013. http://www.cdc.gov/aging/pdf/state-aging-health-in-america-2013.pdf.
15. Jones R.B., Ferraro A.J., Chaudhry A.N., Brogan P., Salama A.D., Smith K.G., et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009, 60:2156-2168.